Gossamer Bio (GOSS) Enterprise Value: 2022-2025
Historic Enterprise Value for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $417.8 million.
- Gossamer Bio's Enterprise Value rose 502.17% to $417.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$347.6 million, marking a year-over-year increase of 65.21%. This contributed to the annual value of -$89.5 million for FY2024, which is 1.33% up from last year.
- Latest data reveals that Gossamer Bio reported Enterprise Value of $417.8 million as of Q3 2025, which was up 526.71% from $66.7 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Enterprise Value ranged from a high of $821.2 million in Q3 2022 and a low of -$150.7 million during Q2 2024.
- In the last 3 years, Gossamer Bio's Enterprise Value had a median value of -$82.2 million in 2023 and averaged -$18.9 million.
- In the last 5 years, Gossamer Bio's Enterprise Value plummeted by 216.62% in 2024 and then soared by 502.17% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's Enterprise Value stood at -$50.7 million in 2022, then slumped by 79.10% to -$90.7 million in 2023, then rose by 1.33% to -$89.5 million in 2024, then spiked by 502.17% to $417.8 million in 2025.
- Its Enterprise Value stands at $417.8 million for Q3 2025, versus $66.7 million for Q2 2025 and -$8.0 million for Q1 2025.